The clinical, laboratory, and pathologic features ofa syndrome in dogs characterized by intermittent pain, fever, neutrophilia, and necrotizing arteritis are described to alert others involved in toxicity testing to the existence of this disorder. It is considered that this idiopathic syndrome is a latent condition, the expression of which can be precipitated in predisposed dogs by experimental treatment, and thus, its occurrence could complicate interpretation of toxicity studies. We have observed the disorder in 14 beagle dogs. The syndrome is rare and most cases for study were supplied by the breeder. Typical clinical signs observed included evidence of pain when the mouth was opened, grunting when lifted, and standing with an arched back and lowered head. Appetite was usually reduced. Body temperature was elevated (e.g., 104-106°F). There was progressive, bilateral atrophy of temporal and cervical musculature. Such signs have been observed to persist unremittingly or, more commonly, with periods of expression and remission. Neutrophilic leukocytosis and thrombocytosis were present. Hemoglobin and hematocrit were usually slightly decreased. Serum total protein was usually normal but albumin was reduced and alpha-2 globulins were markedly increased. Rheumatoid factor was elevated in several dogs. Arteritis was observed histologically and was characterized by necrosis, intimal proliferation, neutrophil and mononuclear cell infiltration in the media and periarterial tissues, and hemorrhage. Amyloidosis was observed in several dogs. The cause of this disorder is unknown. Knowledge of the distinct features of this syndrome should obviate complication of interpretation of results in toxicity studies and hopefully will lead to studies ofthis syndrome to provide an understanding ofits etiopathogenesis.
INTRODUCTION
The literature contains a few clinical and pathology reports of cases in dogs characterized by intermittent pain, fever, neutrophilia, and arteritis. The terms "pain syndrome" and "beagle disease" have been used for such cases; "beagle pain syndrome" is the name used at the College of Veterinary Medicine, Cornell University for a syndrome with such findings (Center, pers. comm.). The syndrome occurs in various breeds and in dogs from various sources, but has been observed most often in the beagle, the breed most widely used for experimental purposes. The clinical, laboratory, and pathologic features of this little known, incompletely charac-*Address correspondence to:Terence J. Hayes, V.M.D., Ph.D., Department of Toxicology and Pathology, Hoffmann-La Roche Inc., Nutley, NewJersey 07110. 1 A brief account of these observations was presented at the 25th Annual Meeting of the Society of Toxicology, 1986 (The Toxicologist 6: 206). 2 Presented at the Toxicology Forum in Aspen, Colorado, July 9-11, 1987. 129 terized syndrome are described here to further alert others involved in toxicity testing to the existence of this syndrome. It is considered that this idiopathic syndrome is a latent condition, the expression of which can be precipitated in predisposed dogs by treatment with experimental compounds. Its incidence can be dose-related in such circumstances. As such, its occurrence could complicate interpretation of toxicity studies.
We first observed the syndrome in a chronic toxicity study with beagle dogs in 1983. It was initially thought to be a bacterial infection but additional instances in the study suggested a relationship to treatment with the experimental compound. However, subsequent occurrences of the syndrome in a study with an unrelated compound, and in untreated dogs at this laboratory and at other locations, have demonstrated that the syndrome was not a simple, direct effect of the compound. We have observed the disorder in 14 beagle dogs. Eight of these dogs displayed the full range of clinical signs and laboratory changes described in this report, 2 dogs displayed only some of the features, and 4 dogs were 
REsULTS

Clinical Features
Typically, the first signs observed were that a dog would indicate pain when its mouth was opened, grunt when lifted, and stand with an arched back, extended neck, and lowered head. The dogs had cervical rigidity in that dorsal and lateral movement of the neck was substantially reduced. The pharyngeal mucosa was reddened in several dogs. Appetite was usually reduced but not completely absent even when clinical signs were marked. Body temperatures were elevated (e.g., 104-106°F). Evidence of pain on handling, particularly in the head and neck regions, increased with time and the dogs displayed a hunched stance and limited, stiff gait. Bilateral tear production in some dogs was decreased to about half normal as assessed by Schirmer tear test strips. Progressive loss ofphysical condition occurred, most notably, bilateral atrophy of temporal and cervical muscles and loss of body weight. With substantial weight loss, the dogs appeared to have a distended abdomen. Typical clinical signs are listed in Table I .
The syndrome usually displayed periodicity of both clinical and laboratory findings; typically an active phase, a period of remission, and the repeat of this pattern for several cycles followed by a long period of remission. Clinical signs have been observed to persist unremittingly for 1-2 months by which time the dogs were in very poor condition (50% weight loss in 1 case) or, alternatively, and more commonly in our experience, the signs occurred for several days or weeks followed by periods of remission (e.g., normal stance and near normal body temperature) lasting for 1-3 weeks followed by recurrence of the syndrome. This periodicity of effects can be noted by the variation in body temperature with time ( Fig. 1 ). Several dogs have died either after a prolonged period of clinical signs or several cycles of clinical expression of the disorder. In 3 instances there was remission without recurrence ofthe syndrome in dogs observed for 8 months after an episode.
Laboratory Features
In blood, taken even in the early stages of the syndrome, there was a neutrophilic leukocytosis. Total white counts of 25-35 thousand were typical early in the disease and counts of 40-80 thousand occurred in marked cases. Mature neutrophils generally accounted for 85-92% of the leukocytes. Platelet counts were generally elevated (e.g., 600-1,000 thousand). Hemoglobin and hematocrit were usually slightly decreased. Serum total protein was usually within the normal range but albumin was reduced, typically to half its normal value. Alpha-2 globulins were markedly increased ( Fig. 2 ) and this could account for the finding of near normal values for total protein together with markedly reduced albumin levels. Erythrocyte sedimentation rate was markedly increased as might be expected in dogs with increased acute phase reactants. Serum calcium was usually slightly decreased (e.g., 9.5 mg/ dl) which is likely the result of reduced serum albumin levels. Salient clinical laboratory features of necrotizing arteritis cases we have observed are given in Table II . Selected laboratory values for a representative dog with necrotizing arteritis are given in Table III . This dog had 3 episodes of the syndrome in terms of clinical and clinical laboratory parameters during a 3-month observation period. Body temperature ( Fig.  1 ) spiked after 3, 7, and 9 weeks of observation. Low values for body weight were present after 4, 7, and 10 weeks and for hemoglobin and hematocrit after 3, 7, and 11 weeks. Total leukocyte counts and absolute segmented neutrophil counts peaked after 4, 7, and 9 weeks and platelet counts peaked about a week later (5, 8, and 11 weeks). Thus, laboratory values increased and decreased with time as did body weight and clinical signs, illustrating periodicity of both clinical and laboratory changes in dogs affected with the syndrome.
Tests for changes in selected immune parameters were performed by consulting laboratories on serum from several dogs. Sera from 3 affected dogs and from 6 normal dogs were assayed for anti-nuclear antibody, hemolytic complement, the C3 factor of complement, rheumatoid factor, and circulating immune complexes (Table IV) . Abnormal values for these parameters occurred only in the 3 dogs with arteritis. Anti-nuclear antibody titer was weakly positive in dogs 404 and 731. Hemolytic complement titer was slightly elevated for dog 587. C3 was slightly decreased for dog 404. Rheumatoid factor titer was positive and immune complexes were increased for dog 731.
Serum from dog 242 for which selected clinical chemistry values are presented in Table III was also TOXICOLOGIC PATHOLOGY assayed for rheumatoid factor and anti-nuclear antibody (CenVet, New York, NY); sera from 28 unaffected dogs were also assayed. Dog 242 was positive for rheumatoid factor but not for anti-nuclear antibody; all other sera were negative for both parameters. Serum from another affected dog (681) was assayed(Specialized Assays, Nashville, TN) for rheumatoid factor and anti-nuclear antibody and found to be positive for the former but not the latter parameter. Blood from dog 681 was negative in a direct Coombs test and serum samples show no abnormal levelsofIgO or IgMto common dog viruses (adenovirus, parainfluenza, herpesvirus, distemper, parvovirus, and coronovirus).
Sera from 2 affected dogs (dogs 404, 587) were assayed(Krakowka, Ohio State University) for IgOand IgM-containingimmune complexesusinga solid phase Clq binding assay and with an ELISAbased indicator system.Both sampleswerenegative.
Pathologic Features
Fewgross pathologicchangeshave been observed considering the marked clinical changes seen in the affected dogs. In one dog, yellow or hemorrhagic areas wereobserved on the epicardium, gallbladder, liver, and spleen. Nodules have been observed in the spleen. Spinal cords wereremoved from 2 dogs; both had gross lesions in the lower cervical region. In one, there was a large, ventral subdural area of hemorrhage and in the other there wereseveralsmall areas of discolorationthat werefound to be an acute meningitis at histopathologic examination. Arteritis was observed either in several organs (polyarteritis) or in a single organ. There was variation in the extent and severity of the arteritis. It ranged from minimal necrotic and inflammatory changesin a single artery to extensive necrosis and a severe inflammatory reaction in multiple organs. The arteries affected ranged in sizefrom small muscular arteries slightly larger than arterioles to medium-sized arteries. The coronary arteries or their branches werecommonly affected but other arteries werealso affected (TableV). In the affected arteries, there were several morphologic alterations: fibrinoid necrosis of the tunica media, neutrophilic infiltrationin the media, endothelial proliferation,and a perivascular mixed cell infiltrate. The temporal sequence of these changes has not been defined. Segmental necrosis of the tunica media ( Fig. 3) is believed to be an early change. Subsequently, there was continued tunica media necrosis, endothelial cell proliferation and a perivascular infiltrate composedof mononuclearand polymorphonuclear white .blood cells (Figs. 4, 5) . Changes directly related to arteritis wererelativelyfew. Thrombosis (Fig. 6 )was the most frequent and was present in multiple organs of 3 dogs. Thrombi were often organized and recanalized. Hemorrhage, fibrosis, infarction, and degenerative changes were occasionally seen in affected organs (Table VI) .
Amyloidosis was observed in dogswith repeated, severe manifestations ofthe syndrome. It was most frequent in the spleen where it was occasionally visible grossly as nodules. The livers of 2 dogs contained extensive deposits of amyloid between the sinusoidal endothelium and the parenchymal cells. The testes and pancreasin 1 dog each werethe other organs which were affected.
The severity of the arteritis has been greatest in animals sacrificed at a time when clinicalsignswere being expressed. Amyloidosis may be an aspect of the chronic stage of the disease in that it has been present in our experience in dogs with the longest history of the disorder.
Immunohistologic staining of meninges for IgO has revealed the presence of immunoglobulin-containing cellsin the inflammatoryinfiltratesurrounding affected vessels.
Occurrence in TOXicity Studies
The 4 instances of the complete syndrome that have occurred in toxicity studies in our laboratory have been in the upper dose groupsdue, we believe, to treatment precipitatingexpressionofa latent disorder. The circumstance of our initial experience with the syndrome suggested this to be the case. The study was a I-year study and 3 clinical instances of the syndrome occurred. The first instance was during the second week of the study where the dog had the syndrome without remission for 7 weeks at which time the dog was sacrificed in a moribund condition.
The second instance began about 9 weeks into the study and continued with periods of remission and recurrence until scheduled sacrifice 4 months later. The third instance began halfway through the study and the dog had repeated episodes of the syndrome for 6 months, at which time the treatment period ended and the dog was assigned to a recovery phase. The dog went into remission within 10 days of cessation of treatment (body temperature returned to normal, clinical signs disappeared, and the total white blood cell count dropped from 72,000 to 12,000 in 10 days) and there was no evidence ofthe syndrome for 3 months, at which time the dog was necropsied. At histopathologic examination, the first dog had necrotizing polyarteritis, the second dog had polyarteritis and amyloidosis, and the third dog had only amyloidosis. The continued expression of the syndrome while the dogs were on treatment and its disappearance in a dog put on recovery suggest a relationship to treatment, but the occurrence of the syndrome in other studies and in non-study dogs has indicated that it was not a simple direct toxicologic consequence of the test compound.
We have tested the hypothesis that treatment can precipitate expression of the latent disease by treating a group of dogs that either had the syndrome (4 spontaneous cases supplied by the breeder) or were littermates of dogs that had shown the syndrome (9 dogs) with the experimental compound used in the study noted above, or with 2 pharmacologicallyrelated compounds in a crossover design with I month of treatment for each cycle of the study. The study also included groups of dogs with no known history of the syndrome nor familial relationship to dogs with the syndrome. The test compound resulted in expression of the syndrome (full clinical and laboratory expression) during the second week of the second treatment cycle of this study in 1 dog that had previously shown the syndrome spontaneously, but neither of the other compounds resulted in expression ofthe syndrome in that dog nor in any other study dog. Upon cessation oftreatment, the signs remitted. The dog that had the syndrome during the study remained asymptomatic for approximately 15 months and then spontaneously expressed the disorder and died with the syndrome in about 3 months. The occurrence in this study ofthe syndrome in a dog that had previously developed it spontaneously, and remission of the syndrome upon withdrawal from treatment, support the concept that the disease can be precipitated in predisposed dogs by experimental treatment.
In another instance, it was reported to us (Abrutyn, pers. comm.) that a beagle dog in a toxicity study developed the same clinical syndrome following the first 2 days of dosing that we have observed. Withdrawal from treatment on 3 occasions over an 84-day period or dosing with vehicle was associated with remission ofthe syndrome. Clinical laboratory finding were similar to our findings and 1 small artery in the heart had arteritis with minimal necrosis. This experience is of particular importance because it supports the concept that expression of the syndrome can be precipitated by experimental treatment and thus complicate a study.
The syndrome described here can, reportedly, occur in pet dogs of various breeds (Center, pers. comm.) and has been reported to us in beagle dogs from 8 other laboratories. One laboratory provided tissues for microscopic examination from a control dog (dog 031, Tables V,-VI) and the changes were indistinguishable from those observed in our cases. The clinical and clinical laboratory findings in this dog (Saunders and Reynolds, pers. comm.) also matched what we have observed. 
DISCUSSION
The findings reported here are not the result of a systematic experimental study, rather they are series of observations made on individual dogs for the purpose of better defining an uncommon, little known syndrome in dogs that can occur spontaneously and under experimental conditions. Our objective was to collect clinical, laboratory, and histopathologic observations on available dogs so that a reasonable description of the syndrome could be provided to others in an effort to allow recognition of this disorder. Our hope is that the syndrome will become better known and be the subject of experimental study.
The literature contains several reports of arteritis in the dog that closely or partially resemble the disorder described here. Brooks (2) reported necrotizing vasculitis in 9 of 32 young adult beagle dogs in a single study in England. In 4 of the dogs, the condition was subclinical and evident only at histopathologic examination. The clinical signs observed and the hematologic, clinical chemistry, and histopathologic changes described are virtually indistinguishable from those in this report. Additionally, as has been our experience, the signs waxed and waned, there was mortality in some dogs, and antibiotic therapy was unsuccessful. Brooks consid- ered the likely etiology of the disease to be of autoimmune origin but expressed concern that, as the etiology ofthe disorder was uncertain, it could reappear in the future.
Harcourt (9) reported polyarteritis in a colony of beagles that occurred with an incidence of 1-9 cases a year from 1968 to 1978. The clinical signs described are similar to those that we have observed. Serum chemistries were not given but hematologic findings included neutrophilia and an increased erythrocyte sedimentation rate. Histopathologic findings in these cases resemble those we have observed in terms of the vascular changes and amyloidosis. We did not observe some of the pathologic changes noted in that study, in particular axonal degeneration and loss of myelin and calcificchanges in leptomeninges, nerves and blood vessels, but the nervous system was emphasized more in Harcourt's cases than in ours.
-Kelly (15) provided a well described clinicalpathologic report of polyarteritis in a 7-year-old crossbred dog. Some resemblances in the clinical and pathologic features he described were observed in our cases but findings including skin lesions, rhinitis, blindness, left shift to the neutrophilia, and widespread petechiation have not been observed in our cases. It can be noted that petechiation, especially on the parietal pleura, was mentioned to us (de Lahunta, pers, comm.) as being common in the instances of beagle pain syndrome they have seen.
These reports provide the most relevant information on cases with a close resemblance to what we have observed but a number of other reports on arteritis in the dog (3, (12) (13) (14) (16) (17) (18) and in humans (19, 20) give valuable information in this subject area. An interesting report on necrotizing vasculitis complicating a toxicity study has been published (21) .
This syndrome would likely be oflittle interest to toxicologists and pathologists were it not a disease that could occur in, and complicate the interpretation of, toxicity studies. Our first encounter with the syndrome was in a toxicity study and, while the signs and findings bore little relationship to findings attributed to the test compound, the instances of the syndrome were limited to the high-dose group and thus, initially, were considered to be related to compound. It was only when the same condition appeared with remarkable clinical similarity in a dog in a subsequent study with a pharmacologically and chemically unrelated compound, that we had a basis to question a direct toxicologic effect for the earlier instances. By describing the findings to the dog supplier, we learned that they occasionally saw such dogs and that a laboratory in Europe had reported to them observing the syndrome in 1981. This led to contact with Drs. Sharon Center, Alexander de Lahunta, and others at the NY State College ofVeterinary Medicine at Cornell University who informed us that they had observed the same syndrome in pet dogs ofvarious breeds and in purpose-bred beagles. They referred to the condition as "beagle pain syndrome" and provided us pathology reports with that name as the diagnosis.
The cause ofthis syndrome is unknown. Pedigree analysis (Glickman, pers. comm.) on affected dogs has not revealed a common genetic background. Viral titers for common viruses of dogs, Brucella titers, and blood cultures have not suggesteda cause. Findings such as fever, neutrophilia, increased al-pha-2 globulins, rheumatoid factor, vasculitis, and the periodicity of signs are suggestive of a Type III hypersensitivity disorder. It is tempting to speculate that the syndrome is an immune complex disease that mayor may not involve an autoimmune component. Of particular interest would be a diagnostic marker of the latent state so that dogs predisposed to the condition could be excluded from studies. To date no marker ofthe latent state has been identified. Felsburg (pers. comm.) indicated that lymphocytes of dogs that have shown the syndrome have decreased responsiveness to mitogens during both active expression of the disease and in periods of remission. Further efforts of this type may provide a diagnostic marker of predisposition to the syndrome.
The serum assays for immune parameters done on several dogs with the arteritis syndrome demonstrated that rheumatoid factor assays were positive but results from other assays were inconclusive. Although only affected dogs showed abnormal values for the parameters given in Table III , there was no consistent pattern ofchange for these parameters and the magnitude of change was not marked. It is considered that the results indicate the possibility of an immunologic disturbance but were not diagnostic. Further testing of this type is indicated.
In humans, most systemic or cutaneous necrotizing vasculitides are believed to have a direct or indirect immunologic basis (4-6, 8) and immunopathogenic mechanisms are also usually suspected in reports ofvasculitis in animals. As stated by Winkelmann (22) , "Vascular inflammation is an integral part of the pathology of all systemic and local disease, and so the term, vasculitis has come to be applied to immunological vascular inflammation syndromes, usually with a clinically distinctive presentation." A discussion of the immunological aspects of vasculitis can be found in Hasler (11) . Further tests to determine levels of complement components (e.g., C3, C4) and for indications of immune complexes (e.g., Clq) and immunohistologic studies should help establish the possibility of an immunopathogenic mechanism for necrotizing polyarteritis.
The presence ofimmunoglobulin-containing cells in the perivascular infiltrate of meningeal tissues that we observed was of interest but is not considered to be evidence of an immunologic basis for the lesion. It is of interest that Harcourt (9) reported finding IgG-containing cells but not free immunoglobulin in leptomeninges in beagles with arteritis. IgG-containing cells were observed but not free immunoglobulin (deposits). In our cases, the cells had the morphologic appearance of plasma cells and could have simply been infiltrating cells. We agree with the approach of Gallagher (7) who, in a study of cranial arteritis in humans, concluded that immunoperoxidase staining of specimens that showed intracellular immunoglobulin but negligible or no staining for extracellular immunoglobulin and complement provided no support for the concept that the arteritis is an immune complex vasculitis. Black (pers. comm.) and Felsburg (pers. comm.) have noted positive staining deposits in the kidneys of dogs with the syndrome and this should encourage further study.
The name "beagle pain syndrome" has been used because the condition was first described to us with the name and because it serves to distinguish the condition from other spontaneous vasculitides in the dog such as that described by Hartman (10) . Nevertheless, the syndrome does not always present primarily as a painful condition nor is the disorder known to be limited to beagles. Either canine polyarteritis syndrome or idiopathic canine polyarteritis might serve as a better name for the condition. For a proper name to be established, more needs to be published on the experience ofothers with this condition so that it can become more widely recognized as a disease entity and then, perhaps, some understanding will develop of its etiology and pathogenesis.
Clinical, laboratory, and pathologic findings in the syndrome are distinct and awareness ofthem should allow accurate diagnosis. The findings have been quite uniform between dogs in the cases we have observed. Knowledge ofthe clinical, laboratory, and pathologic features ofthis syndrome should obviate complication of interpretation of results in toxicity studies and hopefully will lead to studies of this syndrome to provide an understanding of its etiopathogenesis.
